New drug trial targets mysterious swelling disease
NCT ID NCT04602598
Summary
This study tested whether the drug zanubrutinib could help people with IgG4-related disease, a condition that causes painful swelling in glands like those in the face and eyes. Ten participants took the oral drug twice daily for 24 weeks. The main goal was to see if the treatment reduced the size and inflammation of the affected glands.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IGG4 RELATED DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stanford University
Palo Alto, California, 94304, United States
Conditions
Explore the condition pages connected to this study.